{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:38:52Z","timestamp":1792809532266,"version":"4.5.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Foundation Abdelwaheb Ben Ayed (FABA) Tunisia","award":["FABA2025-MJ"],"award-info":[{"award-number":["FABA2025-MJ"]}]},{"name":"Tunisian Ministry of Higher Education and Scientific Research MES","award":["PEJC2025-D1P12"],"award-info":[{"award-number":["PEJC2025-D1P12"]}],"id":[{"id":"https:\/\/ror.org\/05v1m8q81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chromosome Res"],"DOI":"10.1007\/s10577-026-09821-6","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:07:48Z","timestamp":1792764468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MPS1 inhibition as an anticancer strategy: where do we stand?"],"prefix":"10.1007","volume":"34","author":[{"given":"Mohamed","family":"Jema\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghofrane","family":"Kitar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesmine","family":"Lahlaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"9821_CR1","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.3892\/or.2016.5085","volume":"36","author":"I Alimova","year":"2016","unstructured":"Alimova I, Ng J, Harris P, Birks D, Donson A, Taylor MD, Foreman NK, Venkataraman S, Vibhakar R (2016) MPS1 kinase as a potential therapeutic target in medulloblastoma. Oncol Rep 36:2633\u20132640","journal-title":"Oncol Rep"},{"key":"9821_CR2","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/his.15399","volume":"86","author":"A Ashi","year":"2025","unstructured":"Ashi A, Awaji AA, Bond J, Johnson CA, Shaaban AM, Bell SM (2025) Threonine and tyrosine kinase (TTK) mRNA and protein expression in breast cancer; prognostic significance in the neoadjuvant setting. Histopathology 86:916\u2013932","journal-title":"Histopathology"},{"key":"9821_CR3","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.177523","author":"V Bharti","year":"2024","unstructured":"Bharti V, Kumar A, Wang Y, Roychowdhury N, de Lima Bellan D, Kassaye BB, Watkins R, Capece M, Chung CG, Hilinski G et al (2024) TTK inhibitor OSU13 promotes immunotherapy responses by activating tumor STING. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.177523","journal-title":"JCI Insight"},{"key":"9821_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tibs.2025.02.005","volume":"50","author":"VM Bolanos-Garcia","year":"2025","unstructured":"Bolanos-Garcia VM (2025) Mps1 kinase functions in mitotic spindle assembly and error correction. Trends Biochem Sci 50:438\u2013453","journal-title":"Trends Biochem Sci"},{"key":"9821_CR5","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.1021\/bi900530v","volume":"48","author":"E Bourhis","year":"2009","unstructured":"Bourhis E, Lingel A, Phung Q, Fairbrother WJ, Cochran AG (2009) Phosphorylation of a borealin dimerization domain is required for proper chromosome segregation. Biochemistry 48:6783\u20136793","journal-title":"Biochemistry"},{"key":"9821_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2174\/1389202917666161102095508","volume":"18","author":"R Caceres-Gutierrez","year":"2017","unstructured":"Caceres-Gutierrez R, Herrera LA (2017) Centromeric non-coding transcription: opening the black box of chromosomal instability? Curr Genomics 18:227\u2013235","journal-title":"Curr Genomics"},{"key":"9821_CR7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119514119","volume":"119","author":"CY Chan","year":"2022","unstructured":"Chan CY, Chiu DK, Yuen VW, Law CT, Wong BP, Thu KL, Cescon DW, Soria-Bretones I, Cheu JW, Lee D et al (2022) CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma. Proc Natl Acad Sci U S A 119:e2119514119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9821_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1021\/ja037390k","volume":"126","author":"S Chen","year":"2004","unstructured":"Chen S, Zhang Q, Wu X, Schultz PG, Ding S (2004) Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 126:410\u2013411","journal-title":"J Am Chem Soc"},{"key":"9821_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23061488","author":"Y Chen","year":"2018","unstructured":"Chen Y, Yu W, Jiang CC, Zheng JG (2018) Insights into resistance mechanisms of inhibitors to Mps1 C604Y mutation via a comprehensive molecular modeling study. Molecules. https:\/\/doi.org\/10.3390\/molecules23061488","journal-title":"Molecules"},{"key":"9821_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1101\/gad.348773.121","volume":"35","author":"R Chiarle","year":"2021","unstructured":"Chiarle R (2021) Solving the chromosome puzzle of aneuploidy in cancer. Genes Dev 35:1073\u20131075","journal-title":"Genes Dev"},{"key":"9821_CR11","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/bph.13782","volume":"174","author":"M Choi","year":"2017","unstructured":"Choi M, Min YH, Pyo J, Lee CW, Jang CY, Kim JE (2017) TC Mps1 12, a novel Mps1 inhibitor, suppresses the growth of hepatocellular carcinoma cells via the accumulation of chromosomal instability. Br J Pharmacol 174:1810\u20131825","journal-title":"Br J Pharmacol"},{"key":"9821_CR12","doi-asserted-by":"publisher","first-page":"21495","DOI":"10.1074\/jbc.M803026200","volume":"283","author":"ML Chu","year":"2008","unstructured":"Chu ML, Chavas LM, Douglas KT, Eyers PA, Tabernero L (2008) Crystal structure of the catalytic domain of the mitotic checkpoint kinase Mps1 in complex with SP600125. J Biol Chem 283:21495\u201321500","journal-title":"J Biol Chem"},{"key":"9821_CR13","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1021\/bi901970c","volume":"49","author":"ML Chu","year":"2010","unstructured":"Chu ML, Lang Z, Chavas LM, Neres J, Fedorova OS, Tabernero L, Cherry M, Williams DH, Douglas KT, Eyers PA (2010) Biophysical and X-ray crystallographic analysis of Mps1 kinase inhibitor complexes. Biochemistry 49:1689\u20131701","journal-title":"Biochemistry"},{"key":"9821_CR14","doi-asserted-by":"publisher","first-page":"10255","DOI":"10.1158\/0008-5472.CAN-10-2101","volume":"70","author":"R Colombo","year":"2010","unstructured":"Colombo R, Caldarelli M, Mennecozzi M, Giorgini ML, Sola F, Cappella P, Perrera C, Depaolini SR, Rusconi L, Cucchi U et al (2010) Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase. Cancer Res 70:10255\u201310264","journal-title":"Cancer Res"},{"key":"9821_CR15","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1158\/1538-7445.AM2013-2097","volume":"73","author":"R Colombo","year":"2013","unstructured":"Colombo R, Caldarelli M, Giorgini ML, Degrassi A, Ciomei M, Pezzetta D, Ballinari D, Montagnoli A, Pesenti E, Donati D et al (2013) Abstract 2097: targeting aneuploidy with NMS-P153, a tight binder inhibitor of the spindle assembly checkpoint MPS1 (TTK) kinase. Cancer Res 73:2097\u20132097","journal-title":"Cancer Res"},{"key":"9821_CR16","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1158\/1538-7445.AM2015-1638","volume":"75","author":"R Colombo","year":"2015","unstructured":"Colombo R, Burbridge M, Rodriguez M, Cantero F, Caldarelli M, Giorgini ML, Sola F, Ballinari D, Ciomei M, Bosotti R et al (2015) Abstract 1638: preclinical characterization of the novel TTK kinase inhibitor S81694 for the treatment of triple negative breast cancer. Cancer Res 75:1638\u20131638","journal-title":"Cancer Res"},{"issue":"872\u2013883","key":"9821_CR17","first-page":"e875","volume":"28","author":"G Combes","year":"2018","unstructured":"Combes G, Barysz H, Garand C, Gama Braga L, Alharbi I, Thebault P, Murakami L, Bryne DP, Stankovic S, Eyers PA et al (2018) Mps1 phosphorylates Its N-terminal extension to relieve autoinhibition and activate the spindle assembly checkpoint. Curr Biol 28(872\u2013883):e875","journal-title":"Curr Biol"},{"key":"9821_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105279","volume":"39","author":"C Conde","year":"2020","unstructured":"Conde C, Gassmann R (2020) Spindle checkpoint: trapped by the corona, cyclin B1 goes MAD. EMBO J 39:e105279","journal-title":"EMBO J"},{"key":"9821_CR19","doi-asserted-by":"publisher","first-page":"32988","DOI":"10.1074\/jbc.M110.140905","volume":"285","author":"Y Cui","year":"2010","unstructured":"Cui Y, Cheng X, Zhang C, Zhang Y, Li S, Wang C, Guadagno TM (2010) Degradation of the human mitotic checkpoint kinase Mps1 is cell cycle-regulated by APC-cCdc20 and APC-cCdh1 ubiquitin ligases. J Biol Chem 285:32988\u201332998","journal-title":"J Biol Chem"},{"key":"9821_CR20","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1021\/acs.jmedchem.1c01165","volume":"65","author":"A da Silva Santiago","year":"2022","unstructured":"da Silva Santiago A, Schwalm MP, Hu Z, Dos Reis CV, Takarada JE, Mezzomo P, Massirer KB, Kudolo M, Gerstenecker S et al (2022) Development of the first covalent monopolar spindle kinase 1 (MPS1\/TTK) inhibitor. J Med Chem 65:3173\u20133192","journal-title":"J Med Chem"},{"key":"9821_CR21","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1158\/1535-7163.MCT-07-2051","volume":"7","author":"AM D'Alise","year":"2008","unstructured":"D\u2019Alise AM, Amabile G, Iovino M, Di Giorgio FP, Bartiromo M, Sessa F, Villa F, Musacchio A, Cortese R (2008) Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells. Mol Cancer Ther 7:1140\u20131149","journal-title":"Mol Cancer Ther"},{"key":"9821_CR22","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1073\/pnas.1007645108","volume":"108","author":"J Daniel","year":"2011","unstructured":"Daniel J, Coulter J, Woo JH, Wilsbach K, Gabrielson E (2011) High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells. Proc Natl Acad Sci U S A 108:5384\u20135389","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9821_CR23","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1158\/1538-7445.AM2016-2646","volume":"76","author":"J de Man","year":"2016","unstructured":"de Man J, Uitdehaag JCM, Willemsen-Seegers N, Sterrenburg JG, de Wit JJP, de Roos JADM, Prinsen MBW, Buijsman RC, Zaman GJR (2016) Abstract 2646: The unique binding mode of NTRC 0066-0, a novel inhibitor of the spindle assembly checkpoint kinase TTK (Mps1), leads to long target residence time and potent antitumor activity. Cancer Res 76:2646","journal-title":"Cancer Res"},{"key":"9821_CR24","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.4161\/cc.8.21.9939","volume":"8","author":"M Delacour-Larose","year":"2009","unstructured":"Delacour-Larose M, Vu HL, Molla A (2009) Aurora B kinase, an immobile passenger! Cell Cycle 8:3608\u20133609","journal-title":"Cell Cycle"},{"key":"9821_CR25","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.cub.2005.05.020","volume":"15","author":"RK Dorer","year":"2005","unstructured":"Dorer RK, Zhong S, Tallarico JA, Wong WH, Mitchison TJ, Murray AW (2005) A small-molecule inhibitor of Mps1 blocks the spindle-checkpoint response to a lack of tension on mitotic chromosomes. Curr Biol 15:1070\u20131076","journal-title":"Curr Biol"},{"key":"9821_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03192-2","volume":"24","author":"H Du","year":"2024","unstructured":"Du H, Zhang L, Chen J, Chen X, Qiang R, Ding X, Wang Y, Yang X (2024) Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients. Cancer Cell Int 24:20","journal-title":"Cancer Cell Int"},{"key":"9821_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.celrep.2015.05.039","volume":"12","author":"J Espeut","year":"2015","unstructured":"Espeut J, Lara-Gonzalez P, Sassine M, Shiau AK, Desai A, Abrieu A (2015) Natural loss of Mps1 kinase in nematodes uncovers a role for Polo-like kinase 1 in spindle checkpoint initiation. Cell Rep 12:58\u201365","journal-title":"Cell Rep"},{"key":"9821_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nbt1068","volume":"23","author":"MA Fabian","year":"2005","unstructured":"Fabian MA, Biggs WH 3rd, Treiber DK, Atteridge CE, Azimioara MD, Benedetti MG, Carter TA, Ciceri P, Edeen PT, Floyd M et al (2005) A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23:329\u2013336","journal-title":"Nat Biotechnol"},{"key":"9821_CR29","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1038\/s41467-022-34058-2","volume":"13","author":"ES Fischer","year":"2022","unstructured":"Fischer ES, Yu CWH, Hevler JF, McLaughlin SH, Maslen SL, Heck AJR, Freund SMV, Barford D (2022) Juxtaposition of Bub1 and Cdc20 on phosphorylated Mad1 during catalytic mitotic checkpoint complex assembly. Nat Commun 13:6381","journal-title":"Nat Commun"},{"key":"9821_CR30","doi-asserted-by":"publisher","first-page":"14875","DOI":"10.1073\/pnas.2434156100","volume":"100","author":"HA Fisk","year":"2003","unstructured":"Fisk HA, Mattison CP, Winey M (2003) Human Mps1 protein kinase is required for centrosome duplication and normal mitotic progression. Proc Natl Acad Sci U S A 100:14875\u201314880","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9821_CR31","doi-asserted-by":"publisher","first-page":"13427","DOI":"10.1073\/pnas.1400892111","volume":"111","author":"F Foijer","year":"2014","unstructured":"Foijer F, Xie SZ, Simon JE, Bakker PL, Conte N, Davis SH, Kregel E, Jonkers J, Bradley A, Sorger PK (2014) Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress. Proc Natl Acad Sci U S A 111:13427\u201313432","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9821_CR32","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1182\/blood-2021-151124","volume":"138","author":"LV Guilhen Longo","year":"2021","unstructured":"Guilhen Longo LV, McNeil-Laidley B, Cottini F, Hughes T, Hilinski G, Merritt E, Benson DM (2021) Targeting the mitotic checkpoint in myeloma with OSU-13, a novel Mps1\/Ttk inhibitor. Blood 138:2660\u20132660","journal-title":"Blood"},{"key":"9821_CR33","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1158\/0008-5472.CAN-14-3272","volume":"75","author":"MD Gurden","year":"2015","unstructured":"Gurden MD, Westwood IM, Faisal A, Naud S, Cheung KM, McAndrew C, Wood A, Schmitt J, Boxall K, Mak G et al (2015) Naturally occurring mutations in the MPS1 gene predispose cells to kinase inhibitor drug resistance. Cancer Res 75:3340\u20133354","journal-title":"Cancer Res"},{"key":"9821_CR34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.molonc.2013.12.018","volume":"8","author":"B Gyorffy","year":"2014","unstructured":"Gyorffy B, Bottai G, Lehmann-Che J, Keri G, Orfi L, Iwamoto T, Desmedt C, Bianchini G, Turner NC, de The H et al (2014) TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers. Mol Oncol 8:508\u2013519","journal-title":"Mol Oncol"},{"key":"9821_CR35","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6299","volume":"7","author":"Y Han","year":"2019","unstructured":"Han Y, Wu Y, Xu Y, Guo W, Zhang N, Wang X (2019) Molecular mechanism of point mutation-induced Monopolar spindle 1 (Mps1\/TTK) inhibitor resistance revealed by a comprehensive molecular modeling study. PeerJ 7:e6299","journal-title":"PeerJ"},{"key":"9821_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12:31\u201346","journal-title":"Cancer Discov"},{"key":"9821_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1083\/jcb.201002133","volume":"190","author":"L Hewitt","year":"2010","unstructured":"Hewitt L, Tighe A, Santaguida S, White AM, Jones CD, Musacchio A, Green S, Taylor SS (2010) Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex. J Cell Biol 190:25\u201334","journal-title":"J Cell Biol"},{"key":"9821_CR38","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/prot.25174","volume":"84","author":"Y Hiruma","year":"2016","unstructured":"Hiruma Y, Koch A, Dharadhar S, Joosten RP, Perrakis A (2016) Structural basis of reversine selectivity in inhibiting Mps1 more potently than aurora B kinase. Proteins 84:1761\u20131766","journal-title":"Proteins"},{"key":"9821_CR39","doi-asserted-by":"publisher","first-page":"14496","DOI":"10.1074\/jbc.M117.783555","volume":"292","author":"Y Hiruma","year":"2017","unstructured":"Hiruma Y, Koch A, Hazraty N, Tsakou F, Medema RH, Joosten RP, Perrakis A (2017) Understanding inhibitor resistance in Mps1 kinase through novel biophysical assays and structures. J Biol Chem 292:14496\u201314504","journal-title":"J Biol Chem"},{"key":"9821_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","volume":"9","author":"R Hosea","year":"2024","unstructured":"Hosea R, Hillary S, Naqvi S, Wu S, Kasim V (2024) The two sides of chromosomal instability: drivers and brakes in cancer. Signal Transduct Target Ther 9:75","journal-title":"Signal Transduct Target Ther"},{"key":"9821_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2023.149388","volume":"694","author":"X Hu","year":"2024","unstructured":"Hu X, Li G, Li S, Wang Q, Wang Y, Zhang P, Yang T, Yang B, Yu L, Liu Z (2024) TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer. Biochem Biophys Res Commun 694:149388","journal-title":"Biochem Biophys Res Commun"},{"key":"9821_CR42","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1128\/MCB.01837-08","volume":"29","author":"YF Huang","year":"2009","unstructured":"Huang YF, Chang MD, Shieh SY (2009) TTK\/hMps1 mediates the p53-dependent postmitotic checkpoint by phosphorylating p53 at Thr18. Mol Cell Biol 29:2935\u20132944","journal-title":"Mol Cell Biol"},{"key":"9821_CR43","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1021\/acs.jmedchem.5b01811","volume":"59","author":"P Innocenti","year":"2016","unstructured":"Innocenti P, Woodward HL, Solanki S, Naud S, Westwood IM, Cronin N, Hayes A, Roberts J, Henley AT, Baker R et al (2016) Rapid discovery of pyrido[3,4-d]pyrimidine inhibitors of monopolar spindle kinase 1 (MPS1) using a structure-based hybridization approach. J Med Chem 59:3671\u20133688","journal-title":"J Med Chem"},{"key":"9821_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cell.2007.11.046","volume":"132","author":"N Jelluma","year":"2008","unstructured":"Jelluma N, Brenkman AB, van den Broek NJ, Cruijsen CW, van Osch MH, Lens SM, Medema RH, Kops GJ (2008) Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment. Cell 132:233\u2013246","journal-title":"Cell"},{"key":"9821_CR45","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.4161\/cc.20621","volume":"11","author":"M Jemaa","year":"2012","unstructured":"Jemaa M, Galluzzi L, Kepp O, Boileve A, Lissa D, Senovilla L, Harper F, Pierron G, Berardinelli F, Antoccia A et al (2012a) Preferential killing of p53-deficient cancer cells by reversine. Cell Cycle 11:2149\u20132158","journal-title":"Cell Cycle"},{"key":"9821_CR46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/emmm.201200228","volume":"4","author":"M Jemaa","year":"2012","unstructured":"Jemaa M, Vitale I, Kepp O, Berardinelli F, Galluzzi L, Senovilla L, Marino G, Malik SA, Rello-Varona S, Lissa D et al (2012b) Selective killing of p53-deficient cancer cells by SP600125. EMBO Mol Med 4:500\u2013514","journal-title":"EMBO Mol Med"},{"key":"9821_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4161\/cc.23046","volume":"12","author":"M Jemaa","year":"2013","unstructured":"Jemaa M, Galluzzi L, Kepp O, Castedo M, Rello-Varona S, Vitale I, Kroemer G (2013a) Transgenerational cell fate profiling: a method for the graphical presentation of complex cell cycle alterations. Cell Cycle 12:183\u2013190","journal-title":"Cell Cycle"},{"key":"9821_CR48","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/cdd.2013.105","volume":"20","author":"M Jemaa","year":"2013","unstructured":"Jemaa M, Galluzzi L, Kepp O, Senovilla L, Brands M, Boemer U, Koppitz M, Lienau P, Prechtl S, Schulze V et al (2013b) Characterization of novel MPS1 inhibitors with preclinical anticancer activity. Cell Death Differ 20:1532\u20131545","journal-title":"Cell Death Differ"},{"key":"9821_CR49","doi-asserted-by":"publisher","first-page":"885","DOI":"10.18632\/oncotarget.6432","volume":"7","author":"M Jemaa","year":"2016","unstructured":"Jemaa M, Manic G, Lledo G, Lissa D, Reynes C, Morin N, Chibon F, Sistigu A, Castedo M, Vitale I et al (2016) Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition. Oncotarget 7:885\u2013901","journal-title":"Oncotarget"},{"key":"9821_CR50","doi-asserted-by":"publisher","first-page":"16669","DOI":"10.18632\/oncotarget.14291","volume":"8","author":"M Jemaa","year":"2017","unstructured":"Jemaa M, Abdallah S, Lledo G, Perrot G, Lesluyes T, Teyssier C, Roux P, van Dijk J, Chibon F, Abrieu A et al (2017) Heterogeneity in sarcoma cell lines reveals enhanced motility of tetraploid versus diploid cells. Oncotarget 8:16669\u201316689","journal-title":"Oncotarget"},{"key":"9821_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101190","volume":"66","author":"KM Jungles","year":"2025","unstructured":"Jungles KM, Bishop CR, Wilson CM, Liu M, Jungles KR, Wilder-Romans K, Speers CW, Pierce LJ, Rae JM (2025) Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling. Neoplasia 66:101190","journal-title":"Neoplasia"},{"key":"9821_CR52","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2443.2007.01091.x","volume":"12","author":"M Kanai","year":"2007","unstructured":"Kanai M, Ma Z, Izumi H, Kim SH, Mattison CP, Winey M, Fukasawa K (2007) Physical and functional interaction between mortalin and Mps1 kinase. Genes Cells 12:797\u2013810","journal-title":"Genes Cells"},{"key":"9821_CR53","doi-asserted-by":"publisher","first-page":"20232","DOI":"10.1073\/pnas.0710519105","volume":"104","author":"J Kang","year":"2007","unstructured":"Kang J, Chen Y, Zhao Y, Yu H (2007) Autophosphorylation-dependent activation of human Mps1 is required for the spindle checkpoint. Proc Natl Acad Sci U S A 104:20232\u201320237","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9821_CR54","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1158\/1538-7445.AM2025-2164","volume":"85","author":"M Kang","year":"2025","unstructured":"Kang M, Yoo S, Ma S (2025) Abstract 2164: BAL0891 as a dual kinase inhibitor inducing anti-tumor immunity: a promising partner for immune checkpoint inhibitors. Cancer Res 85:2164\u20132164","journal-title":"Cancer Res"},{"key":"9821_CR55","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/em.20476","volume":"50","author":"C Kasbek","year":"2009","unstructured":"Kasbek C, Yang CH, Fisk HA (2009) Mps1 as a link between centrosomes and genomic instability. Environ Mol Mutagen 50:654\u2013665","journal-title":"Environ Mol Mutagen"},{"key":"9821_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115895","author":"HN Khedkar","year":"2021","unstructured":"Khedkar HN, Wang YC, Yadav VK, Srivastava P, Lawal B, Mokgautsi N, Sumitra MR, Wu ATH, Huang HS (2021) In-silico evaluation of genetic alterations in ovarian carcinoma and therapeutic efficacy of NSC777201, as a novel multi-target agent for TTK, NEK2, and CDK1. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22115895","journal-title":"Int J Mol Sci"},{"key":"9821_CR57","doi-asserted-by":"publisher","first-page":"803","DOI":"10.4143\/crt.2024.780","volume":"57","author":"E Kim","year":"2025","unstructured":"Kim E, Kwon WS, Kim TS, Hwang J, Kim S, Rha SY (2025) Identifying anti-cancer effects and exploring the mechanism of an MPS1\/TTK inhibitor in gastric cancer. Cancer Res Treat 57:803\u2013820","journal-title":"Cancer Res Treat"},{"key":"9821_CR58","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ccell.2022.08.015","volume":"40","author":"S Kitajima","year":"2022","unstructured":"Kitajima S, Tani T, Springer BF, Campisi M, Osaki T, Haratani K, Chen M, Knelson EH, Mahadevan NR, Ritter J et al (2022) MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer. Cancer Cell 40:1128\u20131144","journal-title":"Cancer Cell"},{"key":"9821_CR59","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1038\/onc.2015.319","volume":"35","author":"A Koch","year":"2016","unstructured":"Koch A, Maia A, Janssen A, Medema RH (2016) Molecular basis underlying resistance to Mps1\/TTK inhibitors. Oncogene 35:2518\u20132528","journal-title":"Oncogene"},{"key":"9821_CR60","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12282-012-0400-z","volume":"21","author":"CH Kuo","year":"2014","unstructured":"Kuo CH, Lu YC, Tseng YS, Shi CS, Chen SH, Chen PT, Wu FL, Chang YP, Lee YR (2014) Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells. Breast Cancer (Auckl) 21:358\u2013369","journal-title":"Breast Cancer (Auckl)"},{"key":"9821_CR61","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1021\/ml3000879","volume":"3","author":"K Kusakabe","year":"2012","unstructured":"Kusakabe K, Ide N, Daigo Y, Itoh T, Higashino K, Okano Y, Tadano G, Tachibana Y, Sato Y, Inoue M et al (2012) Diaminopyridine-based potent and selective mps1 kinase inhibitors binding to an unusual flipped-peptide conformation. ACS Med Chem Lett 3:560\u2013564","journal-title":"ACS Med Chem Lett"},{"key":"9821_CR62","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nchembio.345","volume":"6","author":"N Kwiatkowski","year":"2010","unstructured":"Kwiatkowski N, Jelluma N, Filippakopoulos P, Soundararajan M, Manak MS, Kwon M, Choi HG, Sim T, Deveraux QL, Rottmann S et al (2010) Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function. Nat Chem Biol 6:359\u2013368","journal-title":"Nat Chem Biol"},{"key":"9821_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/srep44001","volume":"7","author":"J Lagirand-Cantaloube","year":"2017","unstructured":"Lagirand-Cantaloube J, Ciabrini C, Charrasse S, Ferrieres A, Castro A, Anahory T, Lorca T (2017) Loss of centromere cohesion in aneuploid human oocytes correlates with decreased kinetochore localization of the Sac proteins Bub1 and Bubr1. Sci Rep 7:44001","journal-title":"Sci Rep"},{"key":"9821_CR64","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1158\/1538-7445.AM2022-5645","volume":"82","author":"HA Lane","year":"2022","unstructured":"Lane HA, Bachmann F, Zanini E, McSheehy P, Litherland K, Forster-Gross N, Bury L, Vu-Pham D, de Man J, van Riel WE et al (2022) Abstract 5645: BAL0891: a novel dual TTK\/PLK1 mitotic checkpoint inhibitor (MCI) that drives aberrant tumor cell division resulting in potent anti-cancer activity. Cancer Res 82:5645","journal-title":"Cancer Res"},{"key":"9821_CR65","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1016\/j.bmc.2014.06.027","volume":"22","author":"R Laufer","year":"2014","unstructured":"Laufer R, Ng G, Liu Y, Patel NK, Edwards LG, Lang Y, Li SW, Feher M, Awrey DE, Leung G et al (2014) Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides. Bioorg Med Chem 22:4968\u20134997","journal-title":"Bioorg Med Chem"},{"key":"9821_CR66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/19768354.2022.2079718","volume":"26","author":"B Li","year":"2022","unstructured":"Li B, Gu X, Zhang H, Xiong H (2022) Comprehensive analysis of the prognostic value and immune implications of the TTK gene in lung adenocarcinoma: a meta-analysis and bioinformatics analysis. Anim Cells Syst (Seoul) 26:108\u2013118","journal-title":"Anim Cells Syst (Seoul)"},{"key":"9821_CR67","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s00044-024-03286-0","volume":"33","author":"N Li","year":"2024","unstructured":"Li N, Wang J, Wu H, Zheng Z, Liu W, Qin Z (2024) Design and discovery of monopolar spindle kinase 1 (MPS1\/TTK) inhibitors by computational approaches. Med Chem Res 33:1861\u20131886","journal-title":"Med Chem Res"},{"key":"9821_CR68","doi-asserted-by":"publisher","first-page":"38309","DOI":"10.18632\/oncotarget.16213","volume":"8","author":"MAA Libouban","year":"2017","unstructured":"Libouban MAA, de Roos J, Uitdehaag JCM, Willemsen-Seegers N, Mainardi S, Dylus J, de Man J, Tops B, Meijerink JPP, Storchova Z et al (2017) Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell lines. Oncotarget 8:38309\u201338325","journal-title":"Oncotarget"},{"key":"9821_CR69","doi-asserted-by":"publisher","DOI":"10.3892\/or.2024.8760","author":"JS Lim","year":"2024","unstructured":"Lim JS, Kim E, Song JS, Ahn S (2024) Energy\u2011stress\u2011mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple\u2011negative breast cancer. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2024.8760","journal-title":"Oncol Rep"},{"key":"9821_CR70","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.bbrc.2014.07.071","volume":"450","author":"Y Ling","year":"2014","unstructured":"Ling Y, Zhang X, Bai Y, Li P, Wei C, Song T, Zheng Z, Guan K, Zhang Y, Zhang B et al (2014) Overexpression of Mps1 in colon cancer cells attenuates the spindle assembly checkpoint and increases aneuploidy. Biochem Biophys Res Commun 450:1690\u20131695","journal-title":"Biochem Biophys Res Commun"},{"key":"9821_CR71","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev-biochem-061611-090435","volume":"81","author":"X Liu","year":"2012","unstructured":"Liu X, Winey M (2012) The MPS1 family of protein kinases. Annu Rev Biochem 81:561\u2013585","journal-title":"Annu Rev Biochem"},{"key":"9821_CR72","doi-asserted-by":"publisher","first-page":"43660","DOI":"10.1074\/jbc.M111.286229","volume":"286","author":"C Liu","year":"2011","unstructured":"Liu C, van Dyk D, Choe V, Yan J, Majumder S, Costanzo M, Bao X, Boone C, Huo K, Winey M et al (2011) Ubiquitin ligase Ufd2 is required for efficient degradation of Mps1 kinase. J Biol Chem 286:43660\u201343667","journal-title":"J Biol Chem"},{"key":"9821_CR73","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1021\/jm501740a","volume":"58","author":"Y Liu","year":"2015","unstructured":"Liu Y, Lang Y, Patel NK, Ng G, Laufer R, Li SW, Edwards L, Forrest B, Sampson PB, Feher M et al (2015) The discovery of orally bioavailable tyrosine threonine kinase (TTK) inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as anticancer agents. J Med Chem 58:3366\u20133392","journal-title":"J Med Chem"},{"key":"9821_CR74","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/acsmedchemlett.5b00485","volume":"7","author":"Y Liu","year":"2016","unstructured":"Liu Y, Laufer R, Patel NK, Ng G, Sampson PB, Li SW, Lang Y, Feher M, Brokx R, Beletskaya I et al (2016) Discovery of pyrazolo[1,5-a]pyrimidine TTK inhibitors: CFI-402257 is a potent, selective, bioavailable anticancer agent. ACS Med Chem Lett 7:671\u2013675","journal-title":"ACS Med Chem Lett"},{"key":"9821_CR75","doi-asserted-by":"publisher","first-page":"e2413990","DOI":"10.1002\/advs.202413990","volume":"12","author":"B Liu","year":"2025","unstructured":"Liu B, Lu T, Ding M, Zhou X, Jiang Y, Shang J, Sun W, Hu S, Wang X, Zhou X (2025) Targeting TTK inhibits tumorigenesis of T-cell lymphoma through dephosphorylating p38alpha and activating AMPK\/mTOR pathway. Adv Sci (Weinh) 12:e2413990","journal-title":"Adv Sci (Weinh)"},{"key":"9821_CR76","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3324\/haematol.2023.282838","volume":"109","author":"LVG Longo","year":"2024","unstructured":"Longo LVG, Hughes T, McNeil-Laidley B, Cottini F, Hilinski G, Merritt E, Benson DM (2024) TTK\/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma. Haematologica 109:578\u2013590","journal-title":"Haematologica"},{"key":"9821_CR77","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1021\/acs.jmedchem.1c01768","volume":"65","author":"J Lu","year":"2022","unstructured":"Lu J, Huang Y, Huang J, He R, Huang M, Lu X, Xu Y, Zhou F, Zhang Z, Ding K (2022) Discovery of the first examples of threonine tyrosine kinase PROTAC degraders. J Med Chem 65:2313\u20132328","journal-title":"J Med Chem"},{"key":"9821_CR78","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trecan.2021.09.002","volume":"8","author":"DA Lukow","year":"2022","unstructured":"Lukow DA, Sheltzer JM (2022) Chromosomal instability and aneuploidy as causes of cancer drug resistance. Trends Cancer 8:43\u201353","journal-title":"Trends Cancer"},{"key":"9821_CR79","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/1541-7786.MCR-14-0462-T","volume":"13","author":"UB Maachani","year":"2015","unstructured":"Maachani UB, Kramp T, Hanson R, Zhao S, Celiku O, Shankavaram U, Colombo R, Caplen NJ, Camphausen K, Tandle A (2015) Targeting MPS1 enhances radiosensitization of human glioblastoma by modulating DNA repair proteins. Mol Cancer Res 13:852\u2013862","journal-title":"Mol Cancer Res"},{"key":"9821_CR80","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.devcel.2017.03.025","volume":"41","author":"J Maciejowski","year":"2017","unstructured":"Maciejowski J, Drechsler H, Grundner-Culemann K, Ballister ER, Rodriguez-Rodriguez JA, Rodriguez-Bravo V, Jones MJK, Foley E, Lampson MA, Daub H et al (2017) Mps1 regulates kinetochore-microtubule attachment stability via the Ska complex to ensure error-free chromosome segregation. Dev Cell 41:143-156 e146","journal-title":"Dev Cell"},{"key":"9821_CR81","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1021\/acs.bioconjchem.9b00632","volume":"30","author":"VS Madamsetty","year":"2019","unstructured":"Madamsetty VS, Pal K, Dutta SK, Wang E, Thompson JR, Banerjee RK, Caulfield TR, Mody K, Yen Y, Mukhopadhyay D et al (2019) Design and evaluation of PEGylated liposomal formulation of a novel multikinase inhibitor for enhanced chemosensitivity and inhibition of metastatic pancreatic ductal adenocarcinoma. Bioconjug Chem 30:2703\u20132713","journal-title":"Bioconjug Chem"},{"key":"9821_CR82","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1093\/annonc\/mdv293","volume":"26","author":"AR Maia","year":"2015","unstructured":"Maia AR, de Man J, Boon U, Janssen A, Song JY, Omerzu M, Sterrenburg JG, Prinsen MB, Willemsen-Seegers N, de Roos JA et al (2015) Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model. Ann Oncol 26:2180\u20132192","journal-title":"Ann Oncol"},{"key":"9821_CR83","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41416-018-0081-2","volume":"118","author":"ARR Maia","year":"2018","unstructured":"Maia ARR, Linder S, Song JY, Vaarting C, Boon U, Pritchard CEJ, Velds A, Huijbers IJ, van Tellingen O, Jonkers J et al (2018) Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division. Br J Cancer 118:1586\u20131595","journal-title":"Br J Cancer"},{"key":"9821_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138616","volume":"10","author":"R Martinez","year":"2015","unstructured":"Martinez R, Blasina A, Hallin JF, Hu W, Rymer I, Fan J, Hoffman RL, Murphy S, Marx M, Yanochko G et al (2015) Mitotic checkpoint kinase Mps1 has a role in normal physiology which impacts clinical utility. PLoS ONE 10:e0138616","journal-title":"PLoS ONE"},{"key":"9821_CR85","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1073\/pnas.1700234114","volume":"114","author":"JM Mason","year":"2017","unstructured":"Mason JM, Wei X, Fletcher GC, Kiarash R, Brokx R, Hodgson R, Beletskaya I, Bray MR, Mak TW (2017) Functional characterization of CFI-402257, a potent and selective Mps1\/TTK kinase inhibitor, for the treatment of cancer. Proc Natl Acad Sci U S A 114:3127\u20133132","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9821_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2025.102537","volume":"95","author":"M Milan","year":"2025","unstructured":"Milan M (2025) Chromosomal instability in development and disease: beyond cancer evolution. Curr Opin Cell Biol 95:102537","journal-title":"Curr Opin Cell Biol"},{"key":"9821_CR87","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrm2163","volume":"8","author":"A Musacchio","year":"2007","unstructured":"Musacchio A, Salmon ED (2007) The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8:379\u2013393","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9821_CR88","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.chembiol.2020.07.020","volume":"27","author":"DA Nalawansha","year":"2020","unstructured":"Nalawansha DA, Crews CM (2020) PROTACs: an emerging therapeutic modality in precision medicine. Cell Chem Biol 27:998\u20131014","journal-title":"Cell Chem Biol"},{"key":"9821_CR89","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10822-025-00630-3","volume":"39","author":"A Nandy","year":"2025","unstructured":"Nandy A, Boppana K, Phukan S (2025) Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: a case study on kinase degraders. J Comput Aided Mol des 39:51","journal-title":"J Comput Aided Mol des"},{"key":"9821_CR90","doi-asserted-by":"publisher","first-page":"10045","DOI":"10.1021\/jm401395s","volume":"56","author":"S Naud","year":"2013","unstructured":"Naud S, Westwood IM, Faisal A, Sheldrake P, Bavetsias V, Atrash B, Cheung KM, Liu M, Hayes A, Schmitt J et al (2013) Structure-based design of orally bioavailable 1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1). J Med Chem 56:10045\u201310065","journal-title":"J Med Chem"},{"key":"9821_CR91","doi-asserted-by":"crossref","unstructured":"Pachis ST, Kops G (2018) Leader of the SAC: molecular mechanisms of Mps1\/TTK regulation in mitosis. Open Biol 8.","DOI":"10.1098\/rsob.180109"},{"key":"9821_CR92","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1002\/jcb.24197","volume":"113","author":"M Piccoli","year":"2012","unstructured":"Piccoli M, Palazzolo G, Conforti E, Lamorte G, Papini N, Creo P, Fania C, Scaringi R, Bergante S, Tringali C et al (2012) The synthetic purine reversine selectively induces cell death of cancer cells. J Cell Biochem 113:3207\u20133217","journal-title":"J Cell Biochem"},{"key":"9821_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16010056","author":"B Pinto","year":"2023","unstructured":"Pinto B, Silva JPN, Silva PMA, Barbosa DJ, Sarmento B, Tavares JC, Bousbaa H (2023) Maximizing anticancer response with MPS1 and CENPE inhibition alongside apoptosis induction. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics16010056","journal-title":"Pharmaceutics"},{"key":"9821_CR94","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s42003-025-08444-7","volume":"8","author":"G Qi","year":"2025","unstructured":"Qi G, Ma H, Chen J, Gai P, Teng K (2025) TTK activates ATR through RPA2 phosphorylation to promote olaparib resistance in ovarian cancer. Commun Biol 8:1011","journal-title":"Commun Biol"},{"key":"9821_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/open.202500106","volume":"14","author":"L Rebhan","year":"2025","unstructured":"Rebhan L, Furst R, Schollmeyer D, Serafim RAM, Gehringer M (2025) Go for gold: development of a scalable synthesis of [1-(ethoxycarbonyl)cyclopropyl] triphenylphosphonium tetrafluoroborate, a key reagent to explore covalent monopolar spindle 1 inhibitors. ChemistryOpen 14:e202500106","journal-title":"ChemistryOpen"},{"key":"9821_CR96","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.1021\/acs.jmedchem.7b01223","volume":"60","author":"JR Riggs","year":"2017","unstructured":"Riggs JR, Nagy M, Elsner J, Erdman P, Cashion D, Robinson D, Harris R, Huang D, Tehrani L, Deyanat-Yazdi G et al (2017) The discovery of a dual TTK protein kinase\/CDC2-like kinase (CLK2) inhibitor for the treatment of triple negative breast cancer initiated from a phenotypic screen. J Med Chem 60:8989\u20139002","journal-title":"J Med Chem"},{"key":"9821_CR97","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/prot.25651","volume":"87","author":"JC Roorda","year":"2019","unstructured":"Roorda JC, Joosten RP, Perrakis A, Hiruma Y (2019) A crystal structure of the human protein kinase Mps1 reveals an ordered conformation of the activation loop. Proteins 87:348\u2013352","journal-title":"Proteins"},{"key":"9821_CR98","doi-asserted-by":"publisher","first-page":"10148","DOI":"10.1158\/0008-5472.CAN-07-1887","volume":"67","author":"G Salvatore","year":"2007","unstructured":"Salvatore G, Nappi TC, Salerno P, Jiang Y, Garbi C, Ugolini C, Miccoli P, Basolo F, Castellone MD, Cirafici AM et al (2007) A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. Cancer Res 67:10148\u201310158","journal-title":"Cancer Res"},{"key":"9821_CR99","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1158\/2159-8290.CD-16-0645","volume":"7","author":"L Sansregret","year":"2017","unstructured":"Sansregret L, Patterson JO, Dewhurst S, Lopez-Garcia C, Koch A, McGranahan N, Chao WCH, Barry DJ, Rowan A, Instrell R et al (2017) APC\/C dysfunction limits excessive cancer chromosomal instability. Cancer Discov 7:218\u2013233","journal-title":"Cancer Discov"},{"key":"9821_CR100","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1083\/jcb.201001036","volume":"190","author":"S Santaguida","year":"2010","unstructured":"Santaguida S, Tighe A, D\u2019Alise AM, Taylor SS, Musacchio A (2010) Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine. J Cell Biol 190:73\u201387","journal-title":"J Cell Biol"},{"key":"9821_CR101","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.molcel.2024.11.025","volume":"85","author":"N Sasaki","year":"2025","unstructured":"Sasaki N, Homme M, Murayama T, Osaki T, Tenma T, An T, Takegami Y, Tani T, Gedeon PC, Kobayashi Y et al (2025) RNA sensing induced by chromosome missegregation augments anti-tumor immunity. Mol Cell 85:770-786 e777","journal-title":"Mol Cell"},{"key":"9821_CR102","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/sj.embor.7400483","volume":"6","author":"M Schmidt","year":"2005","unstructured":"Schmidt M, Budirahardja Y, Klompmaker R, Medema RH (2005) Ablation of the spindle assembly checkpoint by a compound targeting Mps1. EMBO Rep 6:866\u2013872","journal-title":"EMBO Rep"},{"key":"9821_CR103","doi-asserted-by":"publisher","first-page":"8025","DOI":"10.1021\/acs.jmedchem.9b02035","volume":"63","author":"VK Schulze","year":"2020","unstructured":"Schulze VK, Klar U, Kosemund D, Wengner AM, Siemeister G, Stockigt D, Neuhaus R, Lienau P, Bader B, Prechtl S et al (2020) Treating cancer by spindle assembly checkpoint abrogation: discovery of two clinical candidates, BAY 1161909 and BAY 1217389, targeting MPS1 kinase. J Med Chem 63:8025\u20138042","journal-title":"J Med Chem"},{"key":"9821_CR104","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1021\/acsptsci.4c00405","volume":"7","author":"E Sflakidou","year":"2024","unstructured":"Sflakidou E, Adhikari B, Siokatas C, Wolf E, Sarli V (2024) Development of 2-aminoadenine-based proteolysis-targeting chimeras (PROTACs) as novel potent degraders of monopolar spindle 1 and aurora kinases. ACS Pharmacol Transl Sci 7:3488\u20133501","journal-title":"ACS Pharmacol Transl Sci"},{"key":"9821_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68829-y","volume":"10","author":"S Simon Serrano","year":"2020","unstructured":"Simon Serrano S, Sime W, Abassi Y, Daams R, Massoumi R, Jemaa M (2020) Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma. Sci Rep 10:11997","journal-title":"Sci Rep"},{"key":"9821_CR106","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1158\/1535-7163.MCT-13-0324","volume":"13","author":"RB Slee","year":"2014","unstructured":"Slee RB, Grimes BR, Bansal R, Gore J, Blackburn C, Brown L, Gasaway R, Jeong J, Victorino J, March KL et al (2014) Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase inhibitor NMS-P715. Mol Cancer Ther 13:307\u2013315","journal-title":"Mol Cancer Ther"},{"key":"9821_CR107","doi-asserted-by":"publisher","first-page":"eabq4293","DOI":"10.1126\/sciadv.abq4293","volume":"8","author":"I Soria-Bretones","year":"2022","unstructured":"Soria-Bretones I, Thu KL, Silvester J, Cruickshank J, El Ghamrasni S, Ba-Alawi W, Fletcher GC, Kiarash R, Elliott MJ, Chalmers JJ et al (2022) The spindle assembly checkpoint is a therapeutic vulnerability of CDK4\/6 inhibitor-resistant ER(+) breast cancer with mitotic aberrations. Sci Adv 8:eabq4293","journal-title":"Sci Adv"},{"key":"9821_CR108","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.62347\/CHXD6134","volume":"14","author":"P Srivastava","year":"2024","unstructured":"Srivastava P, Yadav VK, Chang TH, Su EC, Lawal B, Wu AT, Huang HS (2024) In-silico analysis of TMEM2 as a pancreatic adenocarcinoma and cancer-associated fibroblast biomarker, and functional characterization of NSC777201, for targeted drug development. Am J Cancer Res 14:3010\u20133035","journal-title":"Am J Cancer Res"},{"key":"9821_CR109","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.bmc.2017.02.030","volume":"25","author":"Y Sugimoto","year":"2017","unstructured":"Sugimoto Y, Sawant DB, Fisk HA, Mao L, Li C, Chettiar S, Li PK, Darby MV, Brueggemeier RW (2017) Novel pyrrolopyrimidines as Mps1\/TTK kinase inhibitors for breast cancer. Bioorg Med Chem 25:2156\u20132166","journal-title":"Bioorg Med Chem"},{"key":"9821_CR110","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1021\/acs.biochem.9b00848","volume":"59","author":"X Sun","year":"2020","unstructured":"Sun X, Rao Y (2020) PROTACs as potential therapeutic agents for cancer drug resistance. Biochemistry 59:240\u2013249","journal-title":"Biochemistry"},{"key":"9821_CR111","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","volume":"39","author":"JM Suski","year":"2021","unstructured":"Suski JM, Braun M, Strmiska V, Sicinski P (2021) Targeting cell-cycle machinery in cancer. Cancer Cell 39:759\u2013778","journal-title":"Cancer Cell"},{"key":"9821_CR112","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1038\/onc.2017.266","volume":"36","author":"A Szymiczek","year":"2017","unstructured":"Szymiczek A, Carbone M, Pastorino S, Napolitano A, Tanji M, Minaai M, Pagano I, Mason JM, Pass HI, Bray MR et al (2017) Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma. Oncogene 36:6501\u20136507","journal-title":"Oncogene"},{"key":"9821_CR113","doi-asserted-by":"publisher","first-page":"317","DOI":"10.15252\/embr.201541143","volume":"17","author":"MA Tame","year":"2016","unstructured":"Tame MA, Raaijmakers JA, Afanasyev P, Medema RH (2016) Chromosome misalignments induce spindle-positioning defects. EMBO Rep 17:317\u2013325","journal-title":"EMBO Rep"},{"key":"9821_CR114","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/jnci\/djt168","volume":"105","author":"BA Tannous","year":"2013","unstructured":"Tannous BA, Kerami M, Van der Stoop PM, Kwiatkowski N, Wang J, Zhou W, Kessler AF, Lewandrowski G, Hiddingh L, Sol N et al (2013) Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs. J Natl Cancer Inst 105:1322\u20131331","journal-title":"J Natl Cancer Inst"},{"key":"9821_CR115","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1158\/1535-7163.MCT-11-0453","volume":"10","author":"KD Tardif","year":"2011","unstructured":"Tardif KD, Rogers A, Cassiano J, Roth BL, Cimbora DM, McKinnon R, Peterson A, Douce TB, Robinson R, Dorweiler I et al (2011) Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1. Mol Cancer Ther 10:2267\u20132275","journal-title":"Mol Cancer Ther"},{"key":"9821_CR116","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/BJ20121448","volume":"448","author":"P Thebault","year":"2012","unstructured":"Thebault P, Chirgadze DY, Dou Z, Blundell TL, Elowe S, Bolanos-Garcia VM (2012) Structural and functional insights into the role of the N-terminal Mps1 TPR domain in the SAC (spindle assembly checkpoint). Biochem J 448:321\u2013328","journal-title":"Biochem J"},{"key":"9821_CR117","doi-asserted-by":"publisher","first-page":"E1570","DOI":"10.1073\/pnas.1719577115","volume":"115","author":"KL Thu","year":"2018","unstructured":"Thu KL, Silvester J, Elliott MJ, Ba-Alawi W, Duncan MH, Elia AC, Mer AS, Smirnov P, Safikhani Z, Haibe-Kains B et al (2018) Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer. Proc Natl Acad Sci U S A 115:E1570\u2013E1577","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9821_CR118","doi-asserted-by":"publisher","first-page":"6946","DOI":"10.1038\/ncomms7946","volume":"6","author":"SA Touati","year":"2015","unstructured":"Touati SA, Buffin E, Cladiere D, Hached K, Rachez C, van Deursen JM, Wassmann K (2015) Mouse oocytes depend on BubR1 for proper chromosome segregation but not for prophase I arrest. Nat Commun 6:6946","journal-title":"Nat Commun"},{"key":"9821_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/ma14185385","author":"F Tsitouroudi","year":"2021","unstructured":"Tsitouroudi F, Sarli V, Poulcharidis D, Pitou M, Katranidis A, Choli-Papadopoulou T (2021) Aza-reversine promotes reprogramming of lung (MRC-5) and differentiation of mesenchymal cells into osteoblasts. Materials. https:\/\/doi.org\/10.3390\/ma14185385","journal-title":"Materials"},{"key":"9821_CR120","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bbrc.2011.05.010","volume":"409","author":"K Tsuda","year":"2011","unstructured":"Tsuda K, Nishiya N, Umeyama T, Uehara Y (2011) Identification of LY83583 as a specific inhibitor of Candida albicans MPS1 protein kinase. Biochem Biophys Res Commun 409:418\u2013423","journal-title":"Biochem Biophys Res Commun"},{"key":"9821_CR121","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1158\/1538-7445.AM2017-4185","volume":"77","author":"JC Uitdehaag","year":"2017","unstructured":"Uitdehaag JC, Man J, Libouban M, Willemsen-Seegers N, Sterrenburg JG, Wit JJd, Roos JADd, Prinsen MB, Buijsman RC, Zaman GJ (2017a) Abstract 4185: NTRC 1501-0, a TTK kinase inhibitor selected for its long target residence time, completely inhibits tumor growth in the MDA-MB-231 xenograft model for triple-negative breast cancer. Cancer Res 77:4185\u20134185","journal-title":"Cancer Res"},{"key":"9821_CR122","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.jmb.2017.05.014","volume":"429","author":"JCM Uitdehaag","year":"2017","unstructured":"Uitdehaag JCM, de Man J, Willemsen-Seegers N, Prinsen MBW, Libouban MAA, Sterrenburg JG, de Wit JJP, de Vetter JRF, de Roos J, Buijsman RC et al (2017b) Target residence time-guided optimization on TTK kinase results in inhibitors with potent anti-proliferative activity. J Mol Biol 429:2211\u20132230","journal-title":"J Mol Biol"},{"key":"9821_CR123","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/embor.2012.93","volume":"13","author":"MS van der Waal","year":"2012","unstructured":"van der Waal MS, Saurin AT, Vromans MJ, Vleugel M, Wurzenberger C, Gerlich DW, Medema RH, Kops GJ, Lens SM (2012) Mps1 promotes rapid centromere accumulation of Aurora B. EMBO Rep 13:847\u2013854","journal-title":"EMBO Rep"},{"key":"9821_CR124","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/cdd.2010.145","volume":"18","author":"I Vitale","year":"2011","unstructured":"Vitale I, Galluzzi L, Senovilla L, Criollo A, Jemaa M, Castedo M, Kroemer G (2011) Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death Differ 18:1403\u20131413","journal-title":"Cell Death Differ"},{"key":"9821_CR125","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.celrep.2015.06.007","volume":"12","author":"C von Schubert","year":"2015","unstructured":"von Schubert C, Cubizolles F, Bracher JM, Sliedrecht T, Kops G, Nigg EA (2015) Plk1 and Mps1 Cooperatively Regulate the Spindle Assembly Checkpoint in Human Cells. Cell Rep 12:66\u201378","journal-title":"Cell Rep"},{"key":"9821_CR126","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1111\/j.1582-4934.2008.00605.x","volume":"13","author":"W Wang","year":"2009","unstructured":"Wang W, Yang Y, Gao Y, Xu Q, Wang F, Zhu S, Old W, Resing K, Ahn N, Lei M et al (2009) Structural and mechanistic insights into Mps1 kinase activation. J Cell Mol Med 13:1679\u20131694","journal-title":"J Cell Mol Med"},{"key":"9821_CR127","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejmech.2019.04.047","volume":"175","author":"S Wang","year":"2019","unstructured":"Wang S, Zhang M, Liang D, Sun W, Zhang C, Jiang M, Liu J, Li J, Li C, Yang X et al (2019) Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: a medicinal chemistry perspective. Eur J Med Chem 175:247\u2013268","journal-title":"Eur J Med Chem"},{"key":"9821_CR128","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1158\/1538-7445.AM2013-706","volume":"73","author":"A Wengner","year":"2013","unstructured":"Wengner A, Jema\u00e0 M, Galluzzi L, Kepp O, Brands M, Koppitz M, Schulze V, Siemeister G, Mumberg D, Ziegelbauer K et al (2013) Abstract 706: Novel MPS1 inhibitors with potential anticancer activity. Can Res 73:706\u2013706","journal-title":"Can Res"},{"key":"9821_CR129","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1158\/1535-7163.MCT-15-0500","volume":"15","author":"AM Wengner","year":"2016","unstructured":"Wengner AM, Siemeister G, Koppitz M, Schulze V, Kosemund D, Klar U, Stoeckigt D, Neuhaus R, Lienau P, Bader B et al (2016) Novel Mps1 kinase inhibitors with potent antitumor activity. Mol Cancer Ther 15:583\u2013592","journal-title":"Mol Cancer Ther"},{"key":"9821_CR130","first-page":"1","volume":"32","author":"ES Wenzel","year":"2018","unstructured":"Wenzel ES, Singh ATK (2018) Cell-cycle checkpoints and aneuploidy on the path to cancer. In Vivo 32:1\u20135","journal-title":"In Vivo"},{"key":"9821_CR131","doi-asserted-by":"publisher","first-page":"8226","DOI":"10.1021\/acs.jmedchem.8b00690","volume":"61","author":"HL Woodward","year":"2018","unstructured":"Woodward HL, Innocenti P, Cheung KJ, Hayes A, Roberts J, Henley AT, Faisal A, Mak GW, Box G, Westwood IM et al (2018) Introduction of a methyl group curbs metabolism of pyrido[3,4- d]pyrimidine monopolar spindle 1 (MPS1) inhibitors and enables the discovery of the phase 1 clinical candidate N(2)-(2-ethoxy-4-(4-methyl-4 H-1,2,4-triazol-3-yl)phenyl)-6-methyl- N(8)-neopentylpyrido[3,4- d]pyrimidine-2,8-diamine (BOS172722). J Med Chem 61:8226\u20138240","journal-title":"J Med Chem"},{"key":"9821_CR132","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1111\/cas.14505","volume":"111","author":"ZX Wu","year":"2020","unstructured":"Wu ZX, Yang Y, Wang G, Wang JQ, Teng QX, Sun L, Lei ZN, Lin L, Chen ZS, Zou C (2020) Dual TTK\/CLK2 inhibitor, CC-671, selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells. Cancer Sci 111:2872\u20132882","journal-title":"Cancer Sci"},{"key":"9821_CR133","doi-asserted-by":"publisher","first-page":"e2409250","DOI":"10.1002\/advs.202409250","volume":"12","author":"JH Wu","year":"2025","unstructured":"Wu JH, Liu YX, Zong JB, Qiu M, Zhou YF, Li YN, Aili T, Zhao XR, Hu B (2025) TTK inhibition alleviates postinjury neointimal formation and atherosclerosis. Adv Sci (Weinh) 12:e2409250","journal-title":"Adv Sci (Weinh)"},{"key":"9821_CR134","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/ncb2515","volume":"14","author":"Y Yamagishi","year":"2012","unstructured":"Yamagishi Y, Yang CH, Tanno Y, Watanabe Y (2012) MPS1\/Mph1 phosphorylates the kinetochore protein KNL1\/Spc7 to recruit SAC components. Nat Cell Biol 14:746\u2013752","journal-title":"Nat Cell Biol"},{"key":"9821_CR135","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1091\/mbc.e10-04-0298","volume":"21","author":"CH Yang","year":"2010","unstructured":"Yang CH, Kasbek C, Majumder S, Yusof AM, Fisk HA (2010) Mps1 phosphorylation sites regulate the function of centrin 2 in centriole assembly. Mol Biol Cell 21:4361\u20134372","journal-title":"Mol Biol Cell"},{"key":"9821_CR136","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/nar\/gkv1173","volume":"44","author":"ZC Yu","year":"2016","unstructured":"Yu ZC, Huang YF, Shieh SY (2016) Requirement for human Mps1\/TTK in oxidative DNA damage repair and cell survival through MDM2 phosphorylation. Nucleic Acids Res 44:1133\u20131150","journal-title":"Nucleic Acids Res"},{"key":"9821_CR137","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09899-1","volume":"22","author":"J Yu","year":"2022","unstructured":"Yu J, Gao G, Wei X, Wang Y (2022) TTK protein kinase promotes temozolomide resistance through inducing autophagy in glioblastoma. BMC Cancer 22:786","journal-title":"BMC Cancer"},{"key":"9821_CR138","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-17-0342","volume":"16","author":"GJR Zaman","year":"2017","unstructured":"Zaman GJR, de Roos J, Libouban MAA, Prinsen MBW, de Man J, Buijsman RC, Uitdehaag JCM (2017) TTK inhibitors as a targeted therapy for CTNNB1 (beta-catenin) mutant cancers. Mol Cancer Ther 16:2609\u20132617","journal-title":"Mol Cancer Ther"},{"key":"9821_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1447807","volume":"14","author":"E Zanini","year":"2024","unstructured":"Zanini E, Forster-Gross N, Bachmann F, Brungger A, McSheehy P, Litherland K, Burger K, Groner AC, Roceri M, Bury L et al (2024) Dual TTK\/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination. Front Oncol 14:1447807","journal-title":"Front Oncol"},{"key":"9821_CR140","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.4161\/cc.24403","volume":"12","author":"X Zhang","year":"2013","unstructured":"Zhang X, Ling Y, Wang W, Zhang Y, Ma Q, Tan P, Song T, Wei C, Li P, Liu X et al (2013) UV-C irradiation delays mitotic progression by recruiting Mps1 to kinetochores. Cell Cycle 12:1292\u20131302","journal-title":"Cell Cycle"},{"key":"9821_CR141","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12032-019-1320-y","volume":"37","author":"L Zhang","year":"2019","unstructured":"Zhang L, Jiang B, Zhu N, Tao M, Jun Y, Chen X, Wang Q, Luo C (2019) Mitotic checkpoint kinase Mps1\/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCalpha\/ERK1\/2 and PI3K\/Akt pathway. Med Oncol 37:5","journal-title":"Med Oncol"},{"key":"9821_CR142","doi-asserted-by":"crossref","unstructured":"Zhao, X., Chen, Y., Su, H., and Zhang, L. (2023). From classic medicinal chemistry to state\u2010of\u2010the\u2010art interdisciplinary medicine: Recent advances in proteolysis\u2010targeting chimeras technology. Interdiscipl Med 1.","DOI":"10.1002\/INMD.20230004"},{"key":"9821_CR143","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1158\/1535-7163.MCT-18-0864","volume":"18","author":"L Zheng","year":"2019","unstructured":"Zheng L, Chen Z, Kawakami M, Chen Y, Roszik J, Mustachio LM, Kurie JM, Villalobos P, Lu W, Behrens C et al (2019) Tyrosine threonine kinase inhibition eliminates lung cancers by augmenting apoptosis and polyploidy. Mol Cancer Ther 18:1775\u20131786","journal-title":"Mol Cancer Ther"},{"key":"9821_CR144","doi-asserted-by":"publisher","first-page":"B177","DOI":"10.1158\/1535-7163.TARG-17-B177","volume":"17","author":"D Zhu","year":"2018","unstructured":"Zhu D, Deyanat-Yazdi G, Mikolon D, Narla RK, Peng SX, Ning Y, Riggs JR, Boylan JF (2018a) Abstract B177: synthetic lethal approach identifies potent and selective TTK and CLK inhibitor with preclinical anticancer activity in triple-negative breast cancer model. Mol Cancer Ther 17:B177\u2013B177","journal-title":"Mol Cancer Ther"},{"key":"9821_CR145","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1158\/1535-7163.MCT-17-1084","volume":"17","author":"D Zhu","year":"2018","unstructured":"Zhu D, Xu S, Deyanat-Yazdi G, Peng SX, Barnes LA, Narla RK, Tran T, Mikolon D, Ning Y, Shi T et al (2018b) Synthetic lethal strategy identifies a potent and selective TTK and CLK1\/2 inhibitor for treatment of triple-negative breast cancer with a compromised G(1)-S checkpoint. Mol Cancer Ther 17:1727\u20131738","journal-title":"Mol Cancer Ther"}],"container-title":["Chromosome Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10577-026-09821-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10577-026-09821-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10577-026-09821-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:03:25Z","timestamp":1792807405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10577-026-09821-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":145,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9821"],"URL":"https:\/\/doi.org\/10.1007\/s10577-026-09821-6","relation":{},"ISSN":["1573-6849"],"issn-type":[{"value":"1573-6849","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"During the preparation of this work the authors used DeepSeek -V3 for text reformulation and English editing. The authors used Gemini 3.6 Flash to help creating the figures. After using these tool\/service, the authors reviewed and edited the content as needed, and the authors take full responsibility for the content of the published article.","order":1,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","label":"Conflicts of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30"}}